ResultsIQ

ResultsIQ › Latest results › Indegene Limited

Indegene Limited Q1 FY27 earnings call summary

NSE: INDGN · BSE: 544172

Earnings call of 31 Jul 2026, summarised by AI from the filing.

Indegene Q1 FY27 revenue ₹10,631 million, up 39.7% YoY; EBITDA margin 16.9%, with normalization to 19-20% expected by Q4 FY27.

Key takeaways

  1. Q1 revenue ₹10,631 million, up 39.7% YoY and 6% QoQ, strongest first quarter sequential growth in four years.
  2. Margin guidance EBITDA margin expected back in 19% to 20% range in H2 FY27, normalization by Q4 FY27.
  3. Growth driver Broad-based growth led by accounts beyond top 20, which almost doubled YoY in rupee terms.
  4. Key risk Regulatory and policy decisions, especially in the U.S., could impact the industry.

Original filing on BSE

Indegene Limited Q1 FY27 results

As filed: Revenue ₹1,063 cr (+40% year on year), EBITDA ₹174 cr (+12% year on year), PAT ₹116 cr (0% year on year), EBITDA margin 16.4% (−411 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹1,003 cr (+33% year on year), EBITDA ₹164 cr (+11% year on year), PAT ₹79.7 cr (−16% year on year), EBITDA margin 16.3% (−314 bps). Score 41 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit before exceptional items growth was well below it. EBITDA margin fell 314 bps year on year. Consolidated profit -32% but standalone +34%. Profit fell 7% from last quarter. Revenue rose ₹247 cr on a year ago, more than the ₹83.0 cr it added the year before. Share price after the results: +5.3% in 30 days (Nifty 500: −0.9%).
  • Q3 FY26: Revenue ₹942 cr (+31% year on year), EBITDA ₹160 cr (+22% year on year), PAT ₹103 cr (−6% year on year), EBITDA margin 16.9% (−126 bps). Score 56 of 100, In line with trend. EBITDA margin fell 126 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: +5.7% in 29 days (Nifty 500: +0.1%).
  • Q2 FY26: Revenue ₹804 cr (+17% year on year), EBITDA ₹140 cr (+11% year on year), PAT ₹102 cr (+11% year on year), EBITDA margin 17.4% (−93 bps). Score 51 of 100, In line with trend. EBITDA margin fell 93 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 12% from last quarter. Share price after the results: −3.8% in 29 days (Nifty 500: +0.4%).
  • Q1 FY26: Revenue ₹761 cr (+12% year on year), EBITDA ₹156 cr (+21% year on year), PAT ₹116 cr (+32% year on year), EBITDA margin 20.5% (+144 bps). Score 65 of 100, Above trend. EBITDA margin rose 144 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −0.1% in 29 days (Nifty 500: −2.0%).
  • Q4 FY25: Revenue ₹756 cr (+12% year on year), EBITDA ₹147 cr (+5% year on year), PAT ₹118 cr (+24% year on year), EBITDA margin 19.4% (−136 bps). Score 49 of 100, In line with trend. EBITDA margin fell 136 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: +2.8% in 30 days (Nifty 500: +3.1%).
  • Q3 FY25: Revenue ₹720 cr, EBITDA ₹131 cr, PAT ₹110 cr, EBITDA margin 18.2%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹720 cr). Scored once a year-earlier consolidated quarter exists.
  • Q2 FY25: Revenue ₹687 cr, EBITDA ₹126 cr, PAT ₹92.0 cr, EBITDA margin 18.3%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹687 cr). Scored once a year-earlier consolidated quarter exists.

Past price moves after results do not indicate future moves. Not a recommendation.

Indegene Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.